Week 10 Flashcards
Acute Viral Hepatitis
Asymptomatic > symptomatic > fulminant liver failure > death
Nausea, vomiting, abdominal pain, loss of appetite, fever, diarrhea, light colored stools, dark urine, jaundice
Hepatitis A:
- Main features
- transmission
Picornavirus, (+)ss linear RNA, icosahedral, nonenveloped
Main cause of acute hepatitis in US
Low morbidity and mortality, older people tend to be more symptomatic
NO chronic infection
Transmission: fecal-oral transmission
Hepatitis A
Prevention?
pre/post exposure immunization
KILLED vaccine (one serotype)
Can give passive vaccination with antibodies (not recommended)
Hepatitis A
Diagnosis?
IgM anti-HAV (recent infection), Anti-HAV IgG (past infection or vaccine, lifelong immunity
Hepatitis B
Main features
hepadnavirus, enveloped
Partially DS circular DNA
Neutralizing abs to surface antigen protective (anti-HBsAg)
Hepatitis B
Replication cycle
occurs in nucleus
Host DNA repair machinery “fixes” partially ssDNA genome → cccDNA
Host DdRP Pol II transcribes cccDNA → RNA transcript transported into cytoplasm → HBV pre-genome RNA packaged
HBV pre-genome reverse transcribed by HBV reverse transcriptase → cDNA → virus buds and egresses
**convert to cDNA on the WAY OUT instead of the way in
Hepatitis B
Transmission
parenteral transmission - blood/blood-derived body fluids
Can have mother to infant transmission → chronic infection of infant (prevent infection of infant with active and passive immunization immediately at birth)
Hepatitis B
Prevention
pre/post exposure immunization, vaccine
Hepatitis B
Disease
acute liver disease, chronic liver disease, cirrhosis, HCC
Long incubation period
Chronic infection more likely in kids (<5 yrs), but acute illness LESS likely in younger people (vice versa for > 5 yrs)
HBV surface Ag
HBV surface Ag = antigen on surface of HBV → indicates Hep B infection
Anti-HBsAG antibodies
Anti-HBsAG antibodies→ antibody to HBsAg, indicate immunity to HepB
Anti-HB-core antibodies
Anti-HB-core antibodies → IgM (acute) IgG (chronic or prior infection)
IgM is sole marker of infection during window period
HBeAg
HBeAg = sign of infectivity → Anti-HBeAb = sign of low infectivity
Treatment of HepB (4)
1) INF-a
2) Nucleoside/Nucleotide Analogs
3) Acute infection = SUPPORTIVE
4) Neonate of HBsAg+ mother –> vaccinate
IFN-a
Mechanism in Hep B and C
inhibition of transcription and translation of viral genes
inhibition of glycosylation and maturation of viral proteins
inhibition of liberation of newly synthesized viral particles
IFN-a
ADRs
flu-like syndrome,bone marrow suppression, increased susceptibility to bacterial infections, unmask autoimmune disease
NOT given in pregnancy
Entecavir
nucleoSIDE analog
Inhibits DNA polymerase priming, reverse transcription, and DNA-dependent DNA synthesis
Competes with cellular dGTP for viral DNA polymerase activity
Also used in HIV
Tenofovir
nucleoTIDE analog
Also used in HIV
Must be phosphorylated by cellular kinases to active triphosphate form
Hepatitis C
Main features:
Flavivirus, (+)ss linear RNA, icosahedral, enveloped
Hepatitis C
Disease
Acute infections are usually subclinical
Chronic infection possible - 80% go on to chronic infection
Cirrhosis, liver failure, HCC